PRODUCTS
Hangzhou Evershine Pharmaceutical is committed to the new drug process development, intermediate process optimization and industrial expansion. Up to now, our company has successfully achieved industrial production in many projects, including Canagliflozin, Dapagliflozin, Empagliflozin, Ipragliflozin and their intermediates.
At present, our production base is located in Jiangxi Province, with complete pilot-scale to production equipment. Currently, the annual output value of the project in operation is CNY 500 million.
As a research and development base, Hangzhou Keyao implements independent accounting. Currently Keyao is expanding its business in great strides and sincerely recruits people with lofty ideals for common development.